-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
TherapeuticsMD, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
- TherapeuticsMD, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $200K, a 93.3% decline year-over-year.
- TherapeuticsMD, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $1.3M, a 88.8% decline year-over-year.
- TherapeuticsMD, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.3M, a 88.8% decline from 2022.
- TherapeuticsMD, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.6M, a 35.9% decline from 2021.
- TherapeuticsMD, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.1M, a 69.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)